The FDA has formally warned the manufacturer of the popular weight-loss and diabetes drugs for failing to report potential side effects, raising new questions about long-term safety monitoring.
🔗
https://medicalxpress.com/news/2026-03-fda-novo-nordisk-broke-safety.html
#FDAAlert #HealthNews 🌿
medicalxpress.comFDA warns Novo Nordisk broke safety reporting rules
Federal regulators have warned the maker of Ozempic and Wegovy that it failed to report possible drug side effects to the government.
